Literature DB >> 4853767

Prevention of postoperative deep venous thrombosis in legs by orally administered hydroxychloroquine sulphate.

A E Carter, R Eban.   

Abstract

In a series of patients given hydroxychloroquine sulphate by mouth before and after major surgery the incidence of deep venous thrombosis in the legs, as assessed by iodine-125-tagged fibrinogen scanning and venography, was reduced to 5% compared with an incidence of 16% in a similar untreated group of patients.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4853767      PMCID: PMC1611041          DOI: 10.1136/bmj.3.5923.94

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  2 in total

1.  The prevention of postoperative deep venous thrombosis with dextran 70.

Authors:  A E Carter; R Eban
Journal:  Br J Surg       Date:  1973-09       Impact factor: 6.939

2.  Prevention of postoperative deep venous thrombosis and pulmonary embolism.

Authors:  A E Carter; R Eban; R D Perrett
Journal:  Br Med J       Date:  1971-02-06
  2 in total
  22 in total

Review 1.  Use of hydroxychloroquine to prevent thrombosis in systemic lupus erythematosus and in antiphospholipid antibody-positive patients.

Authors:  Michelle Petri
Journal:  Curr Rheumatol Rep       Date:  2011-02       Impact factor: 4.592

2.  Platelet-derived extracellular vesicles released after trauma promote hemostasis and contribute to DVT in mice.

Authors:  Mitchell R Dyer; Wyeth Alexander; Adnan Hassoune; Qiwei Chen; Tomasz Brzoska; Jurgis Alvikas; Yingjie Liu; Shannon Haldeman; Will Plautz; Patricia Loughran; Hui Li; Brian Boone; Yoel Sadovsky; Prithu Sundd; Brian S Zuckerbraun; Matthew D Neal
Journal:  J Thromb Haemost       Date:  2019-07-28       Impact factor: 5.824

Review 3.  Antiphospholipid syndrome: an update for clinicians and scientists.

Authors:  Andrew P Vreede; Paula L Bockenstedt; Jason S Knight
Journal:  Curr Opin Rheumatol       Date:  2017-09       Impact factor: 5.006

Review 4.  Hydroxychloroquine may be beneficial in preeclampsia and recurrent miscarriage.

Authors:  Claire de Moreuil; Zarrin Alavi; Elisabeth Pasquier
Journal:  Br J Clin Pharmacol       Date:  2019-12-17       Impact factor: 4.335

5.  Prophylaxis of venous thromboembolism: analysis of cost effectiveness.

Authors:  E W Salzman; G C Davies
Journal:  Ann Surg       Date:  1980-02       Impact factor: 12.969

Review 6.  Cutaneous lupus erythematosus and cardiovascular disease: current knowledge and insights into pathogenesis.

Authors:  Lisa N Guo; Vinod E Nambudiri
Journal:  Clin Rheumatol       Date:  2020-07-05       Impact factor: 2.980

Review 7.  Pulmonary embolism: current therapeutic concepts.

Authors:  D A Tibbutt; C N Chesterman
Journal:  Drugs       Date:  1976       Impact factor: 9.546

8.  Prevention of postoperative thromboembolism by various treatments. Controlled clinical trial in 632 patients using 125I-fibrinogen uptake test and lung perfusion scans in patients with deep venous thrombosis.

Authors:  G Hör; G Buttermann; W Theisinger; H W Pabst
Journal:  Eur J Nucl Med       Date:  1976-12-30

Review 9.  Antithrombotic drugs: part II.

Authors:  A S Gallus; J Hirsh
Journal:  Drugs       Date:  1976       Impact factor: 9.546

10.  Collaborative overview of randomised trials of antiplatelet therapy--III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.